XML 23 R13.htm IDEA: XBRL DOCUMENT v3.25.2
Discontinued Operations
6 Months Ended
Jun. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

3. DISCONTINUED OPERATIONS

Mural Oncology Separation

In connection with the Separation, the Company and Mural entered into, among other agreements: a separation agreement; a tax matters agreement; and an employee matters agreement, which are described in Note 3, Discontinued Operations in the “Notes to Consolidated Financial Statements” accompanying the Annual Report.

 

Discontinued Operations

The Company determined that the Separation met the criteria for classification of its former oncology business as discontinued operations in accordance with Topic 205. During the three and six months ended June 30, 2025, the Company recorded no losses from discontinued operations. The following summarizes the loss from discontinued operations for the three and six months ended June 30, 2024:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

(In thousands)

 

June 30, 2024

 

 

June 30, 2024

 

Operating expenses from discontinued operations

 

 

 

 

 

 

Cost of goods manufactured

 

$

 

 

$

 

Research and development

 

 

3,913

 

 

 

6,429

 

Selling, general and administrative

 

 

 

 

 

 

Total operating expenses from discontinued operations

 

 

3,913

 

 

 

6,429

 

Operating loss from discontinued operations

 

 

(3,913

)

 

 

(6,429

)

Income tax benefit from discontinued operations

 

 

(613

)

 

 

(1,009

)

Net loss and comprehensive loss from discontinued operations

 

$

(3,300

)

 

$

(5,420

)